Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Clinical trial NCT06483555 · RECRUITING

Trial details

NCT number: NCT06483555
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic Pancreatic Cancer Basal Cell Neoplasm

Start date: 2025-02-06
Primary completion: 2027-08-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.